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ABSTRACT
Background Previous studies report on smoking in Iran
but recent national data on tobacco use (including
cigarette, water-pipe and pipe) have not been reported.
Methods In 2007, 5287 Iranians aged 15e64 years
were sampled from all provinces as part of a national
cross-sectional survey of non-communicable disease
(NCD) risk factors. Data were collected using the
standardised stepwise protocol for NCD risk factor
surveillance of the World Health Organization. Use of
tobacco products was calculated as the sum of smoking
cigarettes/cigars (smoking currently or daily any amount
of factory/hand-made cigarettes or cigars), pipes (daily)
and water pipes (daily).
Results Total current and daily tobacco use was 14.8%
(burden 7.3 million) and 13.7% (burden 6.7 million) when
extrapolated to the Iranian population aged 15e64. The
prevalence of current and daily cigarette smoking was
12.5% (6.1 million; 23.4% males and 1.4% females) and
11.3% (5.6 million; 21.4 males and 1.4 females); former
smokers comprised 1.7 million or 3.4% of the Iranian
population (6.2% males and 0.6% females; mean
cessation age 34.1). The mean age of starting to smoke
was 20.5 years (24.2 males and 20.4 females). The
prevalence of water-pipe smoking was 2.7% (burden
1.3 million; 3.5% males and 1.9% females). Water-pipe
smokers used the water-pipe on average 3.5 times a day
(2.8 males and 4.5 females).
Conclusion The prevalence of tobacco use has not
escalated over the past two decades. Nonetheless, the
burden is high and therefore warrants preventive public
health policies.
Tobacco use is one of the major preventable causes
of premature death around the world.
1 Ninety per
cent of all lung cancers, 70% of chronic bronchitis
and emphysema and about 25% of ischaemic heart
events have been attributed to cigarette smoking.
2
Among 4000 chemicals detected in tobacco smoke,
60 are known or suspected to be carcinogens.
2
According to the World Health Orgnization,
tobacco use in the 20th century resulted in
100 million deaths worldwide. Approximately
5 million deaths a year are attributed to tobacco,
and this is projected to exceed one billion by the end
of 21st century.
3 Approximately 70% of these
deaths will occur in developing countries.
4
Developing nations embrace a disproportionate
share of the global tobacco burden (84% of all
current smokers), comprising 1.3 billion individ-
uals.
1 Recent prevalence estimates for low and
middle-income countries are 49% for men and 8%
for women.
5 In addition, the harmful effects of
passive smoking affect those people around
smokers.
67
To decrease the prevalence of tobacco use and to
eliminate its related dangers, it is necessary to have
a general view of the current condition. The
purpose of this article is to demonstrate the extent
of tobacco smoking in Iran in different strata of age,
sex and residential area based on information from
the third national Surveillance of Risk Factors of
Non-Communicable Diseases (SuRFNCD, 2007).
METHODS
The third national SuRFNCD in Iran, designed
based on the STEPwise guidelines of WHO, was
conducted in May 2007 and involved 5287 Iranian
citizens.
8 This survey was approved by the ethics
committee of the Center for Disease Management
of Iran. The survey sampling was based on random
clusters of 10 males and 10 females living in neigh-
bouring households. The address of the ﬁrst subject
of each cluster was selected from the list of postal
addresses ofthe IranPostCompany.The households
were approached based on a predetermined plan.
Sampling was continued until 20 volunteers were
registered. The study population included non-
institutionalised Iranian citizens aged 15e64 years.
The survey sample was selected proportional to
urban/rural population size of all 30 provinces of
Iran. Participants were visited at their household by
trained interviewers. Oral informed consent was
obtained from participants.
Interviewers administered questionnaires
containing six different domains: identiﬁcation and
demographic information, diet, physical activity,
tobacco use, history of hypertension and history of
diabetes. The tobacco-related questions of the
STEPwise Approach to Chronic Disease Risk Factor
Surveillance are built on the WHO guidelines for
tobacco use surveillance documents. In brief,
respondents were asked about current and daily use
of any amount of any tobacco products including
cigarettes, pipes and water-pipes. Tobacco use by
pipe and ‘chopoq’, a smoking instrument similar to
a pipe, was addressed in one question. Current
cigarette smoking was deﬁned as smoking any
amount of any kind of factory-made cigarettes,
hand-made cigarettes or cigars at the time of the
interview. The ‘current cigarette smokers’ who
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Research papersmoked daily, were deﬁned as ‘daily cigarette smokers’. Water-
pipe and pipe/chopogh smokers were asked if they were daily
habits. All measures considering overlaps were summed to esti-
mate an overall prevalence of tobacco smoking. Respondents
were also asked about history of daily use of any amount of
cigarettes and cigars. Smoking cessation was inferred from this
variable and comprised subjects who had been smoking any type
of cigarettes (factory-made cigarettes, hand-made cigarettes or
cigars) earlier, but they didn’t smoke at the time of the study.
Finally the extent and age of initiation and abstinence of tobacco
product use were recorded if indicated.
Statistical analysis
Complex sample survey analyses were performed by SPSS 16 for
Windows. To extrapolate the results to the Iranian adult popu-
lation, data were weighted directly to the 2006 population of
Iran aged $15 years and #64 years, based on the 2006 national
Iranian census, to match the age (10-year strata), sex and area of
residence (rural/urban). Prevalence rates are presented with 95%
CIs. Means of variables also are expressed with 95% CIs. ORs are
reported where appropriate. All comparisons with external data
were performed using 95% CIs. The burden of cigarette smoking
was calculated by weighting the sample to the 15e64-year-old
population of the country (Iran census 2006).
RESULTS
The total adult population of the country at the time of the
study was about 49 million individuals aged 15e64 with 36%
between 15 years and 24 years of age.
National estimate of prevalence rates of current tobacco
smoking (including cigarette smoking, water-pipe and pipe) was
14.8% overall, 26.1% for men and 3.2% among women (table 1).
Prevalence was highest among respondents aged 35e44 (22.4%).
The prevalence of current cigarette smoking was 12.5% (95%
CI 10.0% to 15.6%), which corresponds to more than 6.1 million
Iranians aged 15e64 (table 2). The highest prevalence of current
cigarette smoking was in individuals aged 35e44 years (19.9%).
Males had much higher rates of current cigarette smoking than
females (23.4% (95% CI 21.2% to 25.8%) vs 1.4% (95% CI 1.0%
to 2.0%); OR¼21.5 (95% CI 16.2 to 27.9)). Current cigarette
smoking was found in 12.7% and 12.1% of residents in urban and
rural areas, respectively (OR ¼ 1.1 (95% CI 0.9 to 2.0)). About
90.5% of current smokers were daily smokers (11.3% of the total
adult population (95% CI 9.0% to 14.1%), representing 5570000
Iranians). Less than 5% of respondents (3.4%; 95% CI 2.7% to
4.3%) were former smokers, representing 1680000 Iranians. The
prevalence of former smokers was highest in those aged 55e64
(7.9%).
In all, 2.7% (95% CI 2.2 to 3.4) or 1341000 Iranians were daily
water-pipes users and 0.3% (95% CI 0.2 to 0.5; 152000 Iranians)
smoked tobacco by chopoq or pipe (table 3). More than half of
tobacco smoking women (ie, 1.9% of overall 3.2%) smoke
tobacco employing water-pipe. Females do not use pipes to
smoke.
On average 13.7 cigarettes were smoked per day among daily
smokers (95% CI 12.1 to 15.3) (table 4). Daily water-pipe
smoking individuals smoked on average 3.5 times a day (95% CI
1.8 to 5.2). Pipe and chopoq daily tobacco smokers smoked 2.2
times a day on average (95% CI 0.8 to 3.6).
The mean age of starting to smoke was 20.4 (95% CI 19.7 to
21.0) years in males, 24.2 (95% CI 21.8 to 26.7) years in females,
and 20.5 (95% CI 19.9 to 21.2) overall (table 4). The age of ﬁrst
smoking experience is almost the same in urban and rural areas
Table 1 Estimates of current and daily tobacco smoking, Iran, 2007
Variable Subcategory
Population
size (’000s)
Current tobacco use Daily tobacco use
Burden
Prevalence (95%
CI) Burden
Prevalence (95%
CI)
Age 15e24 17710 1608050 9.1% (6.8 to 11.9) 1466850 8.3% (6.3 to 10.8)
25e34 12760 1833050 14.4% (11.6 to 17.7) 1706950 13.4% (10.7 to 16.6)
35e44 9000 2014100 22.4% (17.3 to 28.4) 1821900 20.2% (16.0 to 25.3)
45e54 6270 1314200 21.0% (17.1 to 25.4) 1277900 20.4% (16.6 to 24.8)
55e64 3350 501600 15.0% (12.0 to 18.5) 462750 13.8% (11.0 to 17.2)
Sex Male 24840 6487000 26.1% (23.8 to 28.6) 6025000 24.3% (22.1 to 26.6)
Female 24250 784000 3.2% (2.6 to 4.0) 711400 2.9% (2.4 to 3.6)
Residential area Urban area 34520 5031000 14.6% (11.8 to 17.9) 4668250 13.5% (10.9 to 16.7)
Rural area 14570 2240000 15.4% (10.1 to 22.7) 2068150 14.2% (9.5 to 20.6)
TOTAL 49090 7271000 14.8% (12.2 to 17.9) 6736400 13.7% (11.3 to 16.5)
Table 2 Estimates of current and daily cigarette smoking, Iran, 2007
Variable Subcategory
Current cigarette smoking Daily cigarette smoking Smoking cessation
Burden
Prevalence (95%
CI) Burden
Prevalence (CI
95%) Burden
Prevalence (95%
CI)
Age 15e24 1181000 6.7% (4.8 to 9.1) 1019050 5.8% (4.2 to 7.9) 158450 0.9% (0.5 to 1.7)
25e34 1583010 12.4% (9.7 to 15.7) 1444000 11.3% (8.7 to 14.5) 395440 3.1% (2.2 to 4.4)
35e44 1791020 19.9% (14.8 to 26.2) 1591100 17.7% (13.4 to 23.0) 425400 4.7% (3.4 to 6.6)
45e54 1151020 18.4% (14.4 to 23.1) 1109040 17.7% (13.8 to 22.3) 434650 6.9% (5.1 to 9.4)
55e64 448250 13.4% (10.5 to 17.0) 406010 12.1% (9.3 to 15.6) 264860 7.9% (6.0 to 10.4)
Sex Male 5808000 23.4% (21.2 to 25.8) 5311000 21.4% (19.2 to 23.8) 1532000 6.2% (5.2 to 7.3)
Female 346300 1.4% (1.0 to 2.0) 258200 1.1% (0.8 to 1.5) 146800 0.6% (0.4 to 1.0)
Residential area Urban area 4394150 12.7% (10.0 to 16.1) 4010100 11.6% (9.014.8) to 1250400 3.6% (2.8 to 4.7)
Rural area 1760150 12.1% (7.3 to 19.4) 1559100 10.7% (6.6 to 17.0) 428400 2.9% (1.8 to 4.8)
TOTAL 6154300 12.5% (10.0 to 15.6) 5569200 11.3% (9.0 to 14.1) 1678800 3.4% (2.7 to 4.3)
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Research paper(20.7 (95% CI 20.1 to 21.3) years and 20.1 (95% CI 18.3 to 21.9)
years, respectively). Smoking cessation occurred on average at the
age of 34.1 years (33.6 (95% CI 31.6 to 35.7) in men and
42.0 years (95% CI 35.5 to 48.5) in women).
DISCUSSION
Cigarette smoking is the most popular form of smoking tobacco
among Iranian men. However, among Iranian women use of
water-pipe is the most common form of tobacco consumption.
The age of smoking initiation is lower in men. Furthermore the
number of cigarettes smoked a day is more in men compared to
women. The amount increases by increasing age and peaks in
people aged 45e64. Nevertheless, attempts to stop smoking
happen earlier in men than in women. Although men start
smoking earlier than women, earlier abstinence put men into
equal or less risk associated with duration of exposure compared
to women (duration of exposure is 17.8 years for women vs
13.2 years for men).
Cigarette consumption is a stigma for women in Iranian
culture. Thus there is probably some under-reporting about
smoking by females. According to a study done in an urban area
of Iran to compare self-reported and biochemically indicated
rates of tobacco use (by serum levels of cotinine) there was
a signiﬁcant difference between the two measures among
women (1.3% vs 6.7%).
9
The most recent reported prevalence of current tobacco
smoking among Iranian adults aged 15e64 was 14.2% in 2005
(24.1% for men and 4.3% for women) according to WHO in the
MPOWER package; the prevalence of daily tobacco smoking was
11.9% for the total population (20.9% for men and 2.9% for
women).
3 Therefore, the prevalence of tobacco smoking has
remained almost the same among Iranians from 2005 to 2007.
The burden of current tobacco use in 2005 was approximately
7 million and the number of daily tobacco smokers was about
5897000. The burden of current tobacco smoking in our study is
about 7270000 (95% CI 5370000 to 9372000) of whom
6737000 (95% CI 4823000 to 8650000) are daily tobacco users
(table 1). Consequently, based on the CIs, no signiﬁcant change
has occurred during these 2 years.
In the earliest national survey on tobacco smoking in Iran
(1991) cigarette smoking prevalence among Iranians aged 15e69
was 14.6% (27.2% for males and 3.4% for females). In 1999,
cigarette smoking prevalence decreased to 11.7% (24% for males
and 1.5% for females).
10 Compared to estimates from the current
study we infer there is a slight decrease in the prevalence of
cigarette smoking from 1991, with no signiﬁcant change from
Table 3 Estimates of current use of water-pipe and of pipe/chopoq,
Iran, 2007
Variable Subcategory
Current use of water-pipe
Current use of pipe and
chopoq
Burden
Prevalence
(95% CI) Burden
Prevalence
(95% CI)
Age 15e24 489710 2.8% (1.8 to 4.1) 39700 0.2% (0.1 to 0.9)
25e34 338520 2.7% (1.9 to 3.7) 36150 0.3% (0.1 to 0.9)
35e44 266250 3.0% (2.2 to 3.9) 64300 0.7% (0.3 to 1.6)
45e54 173120 2.8% (1.9 to 4.0) 5655 0.1% (0.0 to 0.7)
55e64 73300 2.2% (1.5 to 3.3) 6675 0.2% (0.0 to 0.8)
Sex Male 876350 3.5% (2.7 to 4.7) 140400 0.6% (0.3 to 0.9)
Female 464550 1.9% (1.4 to 2.5) 12080 0.0% (0.0 to 0.4)
Residential
area
Urban 763100 2.2% (1.7 to 2.8) 114300 0.3% (0.2 to 0.6)
Rural 577800 4.0% (3.0 to 5.3) 38180 0.3% (0.1 to 0.9)
TOTAL 1340900 2.7% (2.2 to 3.4) 152480 0.3% (0.2 to 0.5)
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Research paper1999 in all studied strata (age, sex and residential area). Further,
comparing our results with those reported by Azizi et al
11 for
Tehran (10.8%), no statistically signiﬁcant change has occurred
from 2000 to 2007 according to 95% CIs. In addition, no signif-
icant change in current tobacco smoking prevalence was found
when our estimates were compared to a subnational study
(12.6%; 26% in males and 1.4% in females) conducted in 1994 on
the adult population aged 19e70 in an urban area in Iran.
12
Among European countries the lowest rate of daily smoking
in adult men is in Sweden (14.9%) and the highest rate is in
Russia (65%).
3 In general, the prevalence rates are lower in
western European countries (below 30%).
13 The prevalence of
daily cigarette smoking among Iranian men is higher than in
Sweden (21.4% vs 14.9%) but lower than those in western
European nations. The smoking prevalence among women in
Iran is much lower than in all European countries except
Azerbaijan (0.4%).
13 The daily smoking prevalence rate is equal
for men in the USA (20.9%) and in Iran; but it is much higher
among adult females in the USA (15.5%).
3
The prevalence of daily smoking among Iranian men is lower
than in Japan (41% for males and 11.1% for females) and China
(57.1% for males and 3.4% for females). The prevalence of
smoking among females in Iran is the same as in China and is
lower than in Japan; however, the burden of smoking among
Chinese women is noticeably higher because of the large size of
population.
3
Another important comparison is among our neighbouring
countries and those around Persian Gulf. For men, prevalence
rates in Iran are similar to other countries in the region excluding
Pakistan (28.9%) and Turkey (45.1%), which have higher esti-
mates. Iran is more populated than most of its neighbouring
countries and this can make the burden of smoking higher in
Iran. The prevalence of smoking among adult females is higher
than in Iraq (1.6%), and United Arab Emirates (1.2%) but lower
than in Turkey (14.8%) and equal to other countries in this
region.
3
CONCLUSION
Developing nations experience a disproportionate share of the
global tobacco burden. The results of this study provide baseline
information to monitor tobacco control strategies. The preva-
lence of daily smoking in Iran (24.3% in males and 2.9% in
females) is not as high as in most developed nations. Further-
more, the prevalence of smoking in Iran did not increase over the
past decades. Nevertheless, because of the escalating size of the
Iranian adult population, the smoking burden will likely rise in
future.
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What is already known on this subject?
< Developing nations experience a disproportionate share of the
global tobacco burden. Estimates for low and middle-income
countries are 49% for men and 8% for women. Up-to-date
national estimates of the tobacco burden in Iran do not exist.
What this study adds
< The results of this study provide baseline information to
monitor public health strategies for ﬁghting tobacco abuse. The
prevalence of daily smoking in Iran (24.3 in males and 2.9 in
females) is not as high as in developed nations. Further, the
prevalence of smoking in Iran did not increase over the past
two decades. Nevertheless, because of the escalating size of
the Iran population, the smoking burden will likely rise in the
future.
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